Reported about 13 hours ago
U.S. health officials are reassessing a $590 million contract for bird flu vaccines awarded to Moderna under the Biden administration, amid concerns over pandemic preparedness and vaccine oversight. The review follows a significant outbreak of bird flu in the U.S., and while Moderna has prepared for trials, funding uncertainty may jeopardize their efforts. The contract's urgency stemmed from fears that future vaccine funding under the Trump administration might be neglected.
Source: YAHOO